Claudia Vener
Fondazione IRCCS Istituto Nazionale dei Tumori(IT)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Eosinophilic Disorders and Syndromes
Most-Cited Works
- → Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study(2022)174 cited
- → Treatment of refractory chronic GVHD with rituximab: a GITMO study(2007)170 cited
- → The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis(2012)129 cited
- → First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis(2020)127 cited
- → Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT(2010)99 cited
- → Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study(2024)99 cited
- → Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis(2007)84 cited
- → Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates(2015)71 cited
- → The Significance of Bone Marrow Biopsy andJAK2V617FMutation in the Differential Diagnosis Between the “Early” Prepolycythemic Phase of Polycythemia Vera and Essential Thrombocythemia(2008)69 cited
- → Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoieticbone marrow histology(2006)62 cited